Moderna vaccine trial contractors fail to enroll enough people of color, prompting slowdown

“Developing a vaccine that is not used in a fraction of the population is the same as having no vaccine,” Dr. Moncef Slaoui, who runs a program that has funded Moderna’s vaccine and others, said. “It is absolutely useless.”